← Back to Search

Other

Medication - Gabapentin for Facial Pain

Phase 4
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This study is evaluating whether a medication may help reduce pain following oral surgery.

Eligible Conditions
  • Facial Pain
  • Postoperative Pain
  • Acute Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intensity of pain
incidence of adverse effects
time to first rescue analgesic
+1 more
Secondary outcome measures
incidence of pain
intensity of pain on a numeric rating scale (0-10)
length of post-operative hospital-stay

Side effects data

From 2021 Phase 4 trial • 88 Patients • NCT03012815
2%
Allergic reaction
100%
80%
60%
40%
20%
0%
Study treatment Arm
Gabapentin
Benzodiazepine

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Medication - GabapentinExperimental Treatment1 Intervention
Participants of this group will be administered either Gabapentin 900 milligram PO 2-3 hours prior to the surgical procedure.
Group II: Medication - PlaceboPlacebo Group1 Intervention
Participants of this group will be administered either Placebo PO 2-3 hours prior to the surgical procedure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gabapentin
FDA approved

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,355 Total Patients Enrolled

Frequently Asked Questions

~0 spots leftby Apr 2025